leuprolide and Intestinal-Diseases

leuprolide has been researched along with Intestinal-Diseases* in 2 studies

Reviews

1 review(s) available for leuprolide and Intestinal-Diseases

ArticleYear
Bowel endometriosis: diagnosis and management.
    American journal of obstetrics and gynecology, 2018, Volume: 218, Issue:6

    The most common location of extragenital endometriosis is the bowel. Medical treatment may not provide long-term improvement in patients who are symptomatic, and consequently most of these patients may require surgical intervention. Over the past century, surgeons have continued to debate the optimal surgical approach to treating bowel endometriosis, weighing the risks against the benefits. In this expert review we will describe how the recommended surgical approach depends largely on the location of disease, in addition to size and depth of the lesion. For lesions approximately 5-8 cm from the anal verge, we encourage conservative surgical management over resection to decrease the risk of short- and long-term complications.

    Topics: Anal Canal; Conservative Treatment; Contraceptives, Oral, Combined; Danazol; Digestive System Surgical Procedures; Endometriosis; Endosonography; Estrogen Antagonists; Female; Humans; Intestinal Diseases; Laparoscopy; Leuprolide; Magnetic Resonance Imaging; Ovulation Inhibition; Pelvic Pain; Postoperative Complications; Progestins; Rectal Diseases; Ultrasonography

2018

Other Studies

1 other study(ies) available for leuprolide and Intestinal-Diseases

ArticleYear
Intestinal endometriosis without evident pelvic foci treated with gonadotropin-releasing hormone agonist.
    European journal of obstetrics, gynecology, and reproductive biology, 2006, Apr-01, Volume: 125, Issue:2

    Topics: Adult; Endometriosis; Female; Humans; Intestinal Diseases; Intestinal Polyps; Leuprolide

2006